# dACC-Targeted Temporal Interference for Negative and Cognitive Symptoms in Schizophrenia

> clinical trial · VERIFIED · 2026-08-21

Status: RECRUITING · Sponsor: Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University · Condition: Schizophrenia Disorder

- Company: Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
- Sector: neurotech
- Primary source: https://clinicaltrials.gov/study/NCT07658898

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.